Profiel
F.
Michael Yakes worked as a Senior Director at Exelixis, Inc. from 2012 to 2012.
Prior to that, he worked as a Senior Director-Translational Biology at Cleave Therapeutics, Inc. Yakes holds a doctorate degree from Wayne State University (Michigan) and an undergraduate degree from Northern Michigan University.
Eerdere bekende functies van F. Michael Yakes
| Bedrijven | Functie | Einde |
|---|---|---|
| EXELIXIS, INC. | Corporate Officer/Principal | 01-01-2012 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Opleiding van F. Michael Yakes
| Wayne State University (Michigan) | Doctorate Degree |
| Northern Michigan University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
